Severe Psoriasis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis (NCT06846541) | Alumis Inc | 2025-01-08 |
Track Severe Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.